Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

[The preventive effect of 23-valent pneumococcal polysaccharide vaccine against drug-resistant Streptococcus pneumonia in patients with chronic respiratory disease].

Kobayashi N, Watanuki Y, Miyazawa N, Kudo M, Inoue S, Sato T, Mishina K, Takahashi H, Kaneko T, Ishigatsubo Y.

Nihon Kokyuki Gakkai Zasshi. 2009 Dec;47(12):1063-9. Japanese.

PMID:
20058680
2.
3.

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.

Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N; Vaccine Trialists Group.

N Engl J Med. 2003 Oct 2;349(14):1341-8.

4.

Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.

Dagan R.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:16-20. doi: 10.1111/j.1469-0691.2009.02726.x. Review.

5.

Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states.

Imöhl M, Reinert RR, van der Linden M.

Int J Med Microbiol. 2010 Apr;300(4):237-47. doi: 10.1016/j.ijmm.2009.05.005. Epub 2009 Jul 14.

PMID:
19604721
6.

[Effectiveness of pneumococcal polysaccharide vaccine in older patients with chronic respiratory diseases].

Watanuki Y, Takahashi H, Ogura T, Miyazawa N, Nakamura M, Hashizume T, Kozawa S, Tagawa A.

Nihon Kokyuki Gakkai Zasshi. 2006 Apr;44(4):305-11. Japanese.

PMID:
16681246
7.

Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?

Fenoll A, Aguilar L, Granizo JJ, Giménez MJ, Aragoneses-Fenoll L, Mendez C, Tarragó D.

J Antimicrob Chemother. 2008 Dec;62(6):1430-3. doi: 10.1093/jac/dkn413. Epub 2008 Sep 26.

8.

Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis.

Xu Q, Surendran N, Verhoeven D, Klapa J, Ochs M, Pichichero ME.

Vaccine. 2015 Feb 18;33(8):993-1000. doi: 10.1016/j.vaccine.2015.01.014. Epub 2015 Jan 15.

PMID:
25597944
9.

Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.

Picazo JJ.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:4-6. doi: 10.1111/j.1469-0691.2009.02723.x. Review.

10.

Increase in numbers of beta-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage.

Brandileone MC, Casagrande ST, Guerra ML, Zanella RC, Andrade AL, Di Fabio JL.

J Med Microbiol. 2006 May;55(Pt 5):567-74.

PMID:
16585644
11.

Pneumococcal vaccine and patients with pulmonary diseases.

Mirsaeidi M, Ebrahimi G, Allen MB, Aliberti S.

Am J Med. 2014 Sep;127(9):886.e1-8. doi: 10.1016/j.amjmed.2014.05.010. Epub 2014 May 20. Review.

12.

Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.

Lismond A, Carbonnelle S, Verhaegen J, Schatt P, De Bel A, Jordens P, Jacobs F, Dediste A, Verschuren F, Huang TD, Tulkens PM, Glupczynski Y, Van Bambeke F.

Int J Antimicrob Agents. 2012 Mar;39(3):208-16. doi: 10.1016/j.ijantimicag.2011.11.011. Epub 2012 Jan 14.

PMID:
22245497
14.

Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia.

Musher DM, Rueda-Jaimes AM, Graviss EA, Rodriguez-Barradas MC.

Clin Infect Dis. 2006 Oct 15;43(8):1004-8. Epub 2006 Sep 1.

15.

[Prevalence of serotypes and antimicrobial resistance of invasive strains of Streptococcus pneumoniae].

Mantese OC, Paula A, Moraes AB, Moreira TA, Guerra ML, Brandileone MC.

J Pediatr (Rio J). 2003 Nov-Dec;79(6):537-42. Portuguese.

16.

Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine.

Sá-Leão R, Nunes S, Brito-Avô A, Frazão N, Simões AS, Crisóstomo MI, Paulo AC, Saldanha J, Santos-Sanches I, de Lencastre H.

Clin Microbiol Infect. 2009 Nov;15(11):1002-7. doi: 10.1111/j.1469-0691.2009.02775.x. Epub 2009 Apr 23.

17.
18.

Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.

Cheung YB, Zaman SM, Nsekpong ED, Van Beneden CA, Adegbola RA, Greenwood B, Cutts FT.

Pediatr Infect Dis J. 2009 Nov;28(11):990-5. doi: 10.1097/INF.0b013e3181a78185.

PMID:
19536041
19.

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group.

Ortqvist A, Hedlund J, Burman LA, Elbel E, Höfer M, Leinonen M, Lindblad I, Sundelöf B, Kalin M.

Lancet. 1998 Feb 7;351(9100):399-403.

PMID:
9482293
20.

Streptococcus pneumoniae: epidemiology, risk factors, and clinical features.

Ortqvist A, Hedlund J, Kalin M.

Semin Respir Crit Care Med. 2005 Dec;26(6):563-74. Review.

PMID:
16388428
Items per page

Supplemental Content

Write to the Help Desk